Peter Jung

6.7k total citations · 4 hit papers
67 papers, 4.6k citations indexed

About

Peter Jung is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Peter Jung has authored 67 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Surgery. Recurrent topics in Peter Jung's work include Cancer Cells and Metastasis (9 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Urological Disorders and Treatments (7 papers). Peter Jung is often cited by papers focused on Cancer Cells and Metastasis (9 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Urological Disorders and Treatments (7 papers). Peter Jung collaborates with scholars based in Germany, United States and Spain. Peter Jung's co-authors include Heiko Hermeking, Eduard Batlle, Antje Menssen, Elena Sancho, David Rossell, Berlinda Verdoodt, Alexey Epanchintsev, Marta Sevillano, Dmitri Lodygin and Francisco M. Barriga and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Medicine.

In The Last Decade

Peter Jung

62 papers receiving 4.5k citations

Hit Papers

Dependency of Colorectal Cancer on a TGF-β-Driven Program... 2007 2026 2013 2019 2012 2007 2011 2011 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Jung Germany 23 2.3k 1.9k 1.3k 447 443 67 4.6k
Stephen P. Naber United States 37 2.4k 1.0× 1.9k 1.0× 836 0.6× 304 0.7× 700 1.6× 87 4.6k
Maarten F. Bijlsma Netherlands 35 2.2k 1.0× 1.9k 1.0× 915 0.7× 491 1.1× 356 0.8× 135 4.7k
Radzisław Kordek Poland 33 2.0k 0.8× 1.2k 0.6× 951 0.7× 459 1.0× 508 1.1× 218 4.8k
Paul Yaswen United States 44 3.7k 1.6× 2.3k 1.2× 1.1k 0.8× 283 0.6× 565 1.3× 85 6.2k
E. Aubrey Thompson United States 42 3.3k 1.4× 1.6k 0.8× 1.2k 0.9× 481 1.1× 404 0.9× 112 5.0k
Frédéric Hollande Australia 37 1.9k 0.8× 1.5k 0.8× 732 0.6× 332 0.7× 445 1.0× 97 4.1k
Brad St. Croix United States 32 4.1k 1.7× 1.8k 1.0× 1.4k 1.1× 307 0.7× 444 1.0× 58 6.0k
Tim R. Fenton United Kingdom 27 2.7k 1.2× 1.2k 0.6× 1.3k 1.0× 255 0.6× 266 0.6× 51 4.8k
Efstathios N. Stathopoulos Greece 38 1.9k 0.8× 1.9k 1.0× 1.5k 1.1× 363 0.8× 483 1.1× 118 4.9k
Bo R. Rueda United States 47 2.7k 1.1× 1.7k 0.9× 1.2k 0.9× 259 0.6× 570 1.3× 155 6.5k

Countries citing papers authored by Peter Jung

Since Specialization
Citations

This map shows the geographic impact of Peter Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Jung more than expected).

Fields of papers citing papers by Peter Jung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Jung. The network helps show where Peter Jung may publish in the future.

Co-authorship network of co-authors of Peter Jung

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Jung. A scholar is included among the top collaborators of Peter Jung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Jung. Peter Jung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jung, Peter, et al.. (2025). Pädiatrisches Intensivtransport-Register. Zeitschrift für Geburtshilfe und Neonatologie. 229.
2.
Lee, Annemarie L., Peter Jung, Imogen Clark, et al.. (2024). Participant-selected music listening during pulmonary rehabilitation in people with chronic obstructive pulmonary disease: A randomised controlled trial. Chronic Respiratory Disease. 21. 4083715385–4083715385.
4.
Tschurtschenthaler, Markus, Matjaž Rokavec, Miguel G. Silva, et al.. (2022). SMAD4 Loss Induces c-MYC–Mediated NLE1 Upregulation to Support Protein Biosynthesis, Colorectal Cancer Growth, and Metastasis. Cancer Research. 82(24). 4604–4623. 19 indexed citations
5.
Jung, Peter, David Horst, Thomas Kirchner, Frederick Klauschen, & Jens Neumann. (2022). AURKA is a prognostic biomarker for good overall survival in stage II colorectal cancer patients. Pathology - Research and Practice. 235. 153936–153936. 4 indexed citations
6.
Wiechmann, Svenja, Marlies Michl, Jens Neumann, et al.. (2020). Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer. Cell Communication and Signaling. 18(1). 102–102. 13 indexed citations
7.
Brandl, Lydia, Yina Zhang, Andrea Sendelhofert, et al.. (2019). Targeting c-MYC through Interference with NAMPT and SIRT1 and Their Association to Oncogenic Drivers in Murine Serrated Intestinal Tumorigenesis. Neoplasia. 21(10). 974–988. 10 indexed citations
8.
Mora‐Buch, Rut, Isabella Dotti, Núria Planell, et al.. (2015). Epithelial IL-1R2 acts as a homeostatic regulator during remission of ulcerative colitis. Mucosal Immunology. 9(4). 950–959. 29 indexed citations
9.
Moritz, Katharina, Wolfgang Hemmer, Peter Jung, et al.. (2013). Effect of a Fructose and Lactose Elimination Diet in Patients with Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Study. Journal of Gastroenterology and Hepatology Research. 2(10). 833–839. 9 indexed citations
10.
Jackstadt, René, Peter Jung, & Heiko Hermeking. (2013). AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation. Cell Death and Disease. 4(8). e775–e775. 30 indexed citations
11.
Calon, Alexandre, Elisa Espinet, Sergio Palomo‐Ponce, et al.. (2012). Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation. Cancer Cell. 22(5). 571–584. 826 indexed citations breakdown →
12.
Jung, Peter & Heiko Hermeking. (2009). The c-MYC-AP4-p21 cascade. Cell Cycle. 8(7). 982–989. 74 indexed citations
13.
Menssen, Antje, Alexey Epanchintsev, Dmitri Lodygin, et al.. (2007). c-MYC Delays Prometaphase by Direct Transactivation of MAD2 and BubR1: Identification of Mechanisms Underlying c-MYC-Induced DNA Damage and Chromosomal Instability. Cell Cycle. 6(3). 339–352. 76 indexed citations
14.
Robertson, Val J., Alex R. Ward, & Peter Jung. (2005). The effect of heat on tissue extensibility: A comparison of deep and superficial heating. Archives of Physical Medicine and Rehabilitation. 86(4). 819–825. 83 indexed citations
15.
Jung, Peter, Reinhart Jarisch, & Wolfgang Hemmer. (2005). Hypersensitivity from dental acrylates in a patient previously sensitized to artificial nails. Contact Dermatitis. 53(2). 119–120. 18 indexed citations
16.
Hofmann, Stefanie, Helmut Grasberger, Peter Jung, et al.. (2002). The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression.. PubMed. 7(4). 171–6. 57 indexed citations
17.
Tacke, Josef, Gerhard Adam, Patrick Haage, et al.. (2001). Diuretic-enhanced gadolinium excretory MR urography: comparison of conventional gradient-echo sequences and echo-planar imaging. European Radiology. 11(1). 18–27. 29 indexed citations
19.
Brauers, A., Peter Jung, & G. Jakse. (1999). Tumor-Adopted Diagnosis of Bladder Cancer. Urologia Internationalis. 63(1). 22–26. 1 indexed citations
20.
Bücker, Arno, Gerhard Adam, J. Neuerburg, et al.. (1998). Gadolinium-enhanced excretory MR urography after low-dose diuretic injection: comparison with conventional excretory urography.. Radiology. 209(1). 147–157. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026